UBS Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.3M | Buy |
552,343
+48,180
| +10% | +$988K | ﹤0.01% | 2320 |
|
2025
Q1 | $10.3M | Buy |
504,163
+75,373
| +18% | +$1.54M | ﹤0.01% | 2330 |
|
2024
Q4 | $9.7M | Sell |
428,790
-3,954
| -0.9% | -$89.5K | ﹤0.01% | 2367 |
|
2024
Q3 | $10.7M | Buy |
432,744
+95,488
| +28% | +$2.35M | ﹤0.01% | 1632 |
|
2024
Q2 | $7.8M | Buy |
337,256
+13,370
| +4% | +$309K | ﹤0.01% | 1785 |
|
2024
Q1 | $7.8M | Buy |
323,886
+206,310
| +175% | +$4.97M | ﹤0.01% | 1797 |
|
2023
Q4 | $2.71M | Buy |
117,576
+1,241
| +1% | +$28.6K | ﹤0.01% | 2570 |
|
2023
Q3 | $2.37M | Buy |
116,335
+5,267
| +5% | +$107K | ﹤0.01% | 2415 |
|
2023
Q2 | $2.59M | Buy |
111,068
+4,938
| +5% | +$115K | ﹤0.01% | 2479 |
|
2023
Q1 | $2.47M | Sell |
106,130
-8,903
| -8% | -$207K | ﹤0.01% | 2407 |
|
2022
Q4 | $2.9M | Sell |
115,033
-31,183
| -21% | -$785K | ﹤0.01% | 2258 |
|
2022
Q3 | $3.86M | Sell |
146,216
-9,580
| -6% | -$253K | ﹤0.01% | 1897 |
|
2022
Q2 | $4.5M | Sell |
155,796
-31,682
| -17% | -$916K | ﹤0.01% | 1840 |
|
2022
Q1 | $6.46M | Sell |
187,478
-120,603
| -39% | -$4.16M | ﹤0.01% | 1732 |
|
2021
Q4 | $13.5M | Buy |
308,081
+78,614
| +34% | +$3.44M | ﹤0.01% | 1343 |
|
2021
Q3 | $11.6M | Sell |
229,467
-6,768
| -3% | -$343K | ﹤0.01% | 1430 |
|
2021
Q2 | $12.3M | Buy |
236,235
+448
| +0.2% | +$23.3K | ﹤0.01% | 1376 |
|
2021
Q1 | $10.8M | Buy |
235,787
+49,022
| +26% | +$2.24M | ﹤0.01% | 1397 |
|
2020
Q4 | $8.58M | Buy |
186,765
+99,284
| +113% | +$4.56M | ﹤0.01% | 1479 |
|
2020
Q3 | $3.41M | Buy |
87,481
+87,469
| +728,908% | +$3.41M | ﹤0.01% | 1992 |
|
2020
Q2 | $0 | Buy |
+12
| New | – | ﹤0.01% | 7174 |
|
2020
Q1 | – | Sell |
-300
| Closed | -$9K | – | 7098 |
|
2019
Q4 | $9K | Buy |
300
+232
| +341% | +$6.96K | ﹤0.01% | 6257 |
|
2019
Q3 | $2K | Sell |
68
-22
| -24% | -$647 | ﹤0.01% | 6758 |
|
2019
Q2 | $2K | Buy |
+90
| New | +$2K | ﹤0.01% | 6738 |
|